Status:
COMPLETED
B2-Adrenergic Receptor Polymorphisms
Lead Sponsor:
Connecticut Children's Medical Center
Conditions:
Status Asthmaticus
Eligibility:
All Genders
2-18 years
Brief Summary
Beta(2)-adrenergic receptor (BAR) agonists are the most important group of drugs used in the treatment of asthma. In children unresponsive to inhaled BAR agonist therapy, higher dose systemic BAR agon...
Detailed Description
This study has both a prospective and a retrospective arm. In the retrospective arm, patients with a history of admission to the ICU with a severe asthma exacerbation are contacted by phone and mail a...
Eligibility Criteria
Inclusion
- (1) Admission to the CCMC PICU with a primary admission diagnosis of status asthmaticus. (2) Age between 2 years and 18 years.
Exclusion
- Pre-existing chronic disease (other than asthma)
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00279786
Start Date
December 1 2005
End Date
January 1 2009
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CT Children's Medical Center
Hartford, Connecticut, United States, 06106